Pulmonary delivery of brittle matrix powders produced by thin film freezing
Recently, the portfolio of compounds approved for inhalation therapy has expanded rapidly for lung disease therapies. The rationale for this delivery approach includes a more targeted and localized delivery to the diseased site with reduced systemic exposure, potentially leading to decreased adverse...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
2015
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/2152/28734 |